CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19

CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19

Shots:

  • CEPI reports its seventh COVID-19 vaccine project and will invest $620,000 to HKU for the development of vaccine candidate against COVID-19, making the total investment of CEPI’s in COVID-19 vaccine R&D to $24.3M
  • CEPI will provide initial funding to HKU for preclinical testing of their vaccine candidate and will provide further funding for clinical testing, following the results of preclinical studies
  • The collaboration is a result of the global call for proposals, issued by CEPI in early Feb, which invited funding applications for proven vaccine technology which can be used to develop a vaccine against COVID-19

Click here ­to­ read full press release/ article | Ref: CEPI | Image: CEPI